跳至主要内容
临床试验/IRCT201407242602N12
IRCT201407242602N12已完成3 期

Effect of Supplementation of Hesperidin on Serum Glucose, Insulin, Insulin Resistance, Lipid Profile, Hemoglobin A1C, hs-CRP and IL6 in Type II Diabetic Mellitus Patients

Iran University Medical Science0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • Being volunteer or Wishing to attend 2.diagnosed with type 2 diabetes for at least 1 year (FPG = 126 mg/dl or 2hPG = 200 mg/dl)3. At least one year history of diabet 4.
  • Not using tobacco 5. Lack of cardiovascular disease, liver disease, kidney disease, chronic inflammatory disease of the gastrointestinal tract 6.HbA1C < 8% 7. 20-65 y old 8. Lack of insulin 9. Not drinking alcohol 10. BMI<35 kg/m2 11. Not using any supplements, antioxidants and vitamins in the last 3 months 12. Not pregnant or nursing 13.TG<400 mg/dl 14. The absence of any skin allergies or digestive antioxidant supplements and vitamins. Exclusion criteria 1.The use of antioxidant supplements and vitamins 2.Use of insulin 3. See allergy symptoms at any time during the study 4.Taking over500ml beverages rich in flavonoids include tea, coffee, citrus juice, which it is determined by taking the 24-hour dietary recalls 5. Accept less than 70 6. Follow weight loss diets 7. NSAID nonsteroidal anti-inflammatory drugs and estrogens, oral contraceptives, anticonvulsants, corticosteroids

排除标准

  • 未提供

研究者

发起方
Iran University Medical Science

相似试验